Rick Larsen
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsRick Larsen bought $1,001 - $15,000 in $ODFL on 2025-10-06 — 56 days before the Non-Domiciled CDL Integrity Act (HR5688) was reported out of committee, a bill that could restrict commercial driver's licenses.
Rick Larsen bought $1,001 - $15,000 in $ABT on 2025-10-06 — 57 days before the Medical Foods and Formulas Access Act of 2025 (S3304) which expands federal health program coverage for medical foods.
Rick Larsen bought $1,001 - $15,000 in $WMT on 2025-10-06 — 66 days before HR6634, establishing a refundable childhood education tax credit, which could increase disposable income for families.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $ABT | Abbott Laboratories Common Stock | $1K-$15K | $133.74 | — | — | Oct 6, 2025 |
| BUY | $AEP | American Electric Power Company, Inc. | $1K-$15K | $115.66 | — | — | Oct 6, 2025 |
| BUY | $WMT | Walmart Inc. Common Stock | $1K-$15K | $102.70 | — | — | Oct 6, 2025 |
| SELL | $CL | Colgate-Palmolive Company Common Stock | $1K-$15K | $77.45 | — | — | Oct 6, 2025 |
| SELL | $ODFL | Old Dominion Freight Line, Inc. - Common Stock | $1K-$15K | $142.82 | — | — | Oct 6, 2025 |
| SELL | $ZTS | Zoetis Inc. Class A Common Stock | $1K-$15K | $145.36 | — | — | Oct 6, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Thyroid Disease CARE Act of 2025
HR6897 (Thyroid Disease CARE Act) authorizes $30M/year for five years for thyroid disease research and improved diagnostics. The bill is in early stage — referred to House Energy and Commerce Committee on December 18, 2025. Real market data shows diagnostic stocks trending negative over the past 30 days, with Labcorp down 1.53% and Abbott down 11.85%. Any impact is procedural and speculative at this stage.
To amend the Internal Revenue Code of 1986 to establish a refundable childhood education tax credit with monthly advance payments.
HR6634, introduced by Rep. Fields (D-LA) on 2025-12-11, proposes a refundable monthly child tax credit of $667/child for education expenses (up to $8,004/year per child), phased out above 300% of the federal poverty line. The bill is at an early stage — referred to the House Ways and Means Committee — with no further action recorded as of analysis date 2026-04-30. Consumer discretionary and mass-market retailers (WMT, TGT, AMZN) are structurally positioned to benefit from increased household spending, though passage is highly uncertain given the ~$2-3 trillion 10-year fiscal cost and partisan dynamics. HAS, MAT, and DIS have moderate upside exposure as secondary beneficiaries of incremental family spending.
Medical Nutrition Therapy Act of 2025
Bipartisan bill to expand Medicare MNT coverage to obesity, cancer, eating disorders, and HIV/AIDS — currently in early House committee stage with 17 cosponsors and a companion Senate bill. Expands the addressable market for nutrition therapy services within Medicare by 3-5x. UNH and CVS stand to benefit from increased patient volume in their integrated care and pharmacy networks, though passage is not guaranteed in 2026.
LET’S Protect Workers Act
HR6597 (LET'S Protect Workers Act) would dramatically increase civil penalties for child labor and wage/hour violations, raising maximum per-violation fines ~10x to $150,000 per employee. The bill is in early committee stage with no immediate market impact, but it represents a structural regulatory risk for large hourly-workforce employers. Dollar General ($DG) and Dollar Tree ($DLTR) face the highest proportional exposure given thin margins and history of violations.
Non-Domiciled CDL Integrity Act
The Non-Domiciled CDL Integrity Act (HR5688), awaiting floor action in the House, will restrict CDL issuance for non-domiciled individuals, exacerbating the existing driver shortage. This regulation will increase labor costs for trucking firms like JBHT, ODFL, and XPO, and raise supply chain expenses for retailers like WMT. Recent market data shows JBHT up 16.18% in 30 days, ODFL up 8%, XPO up 12.56%, and WMT up 4.01%, but the bill represents a structural cost headwind that is not yet priced in.
To expand the sharing of information with respect to suspected violations of intellectual property rights in trade.
HR4930 expands CBP's authority to share IP violation data with online marketplaces and brand owners, structurally reducing enforcement costs for $AMZN and $EBAY while protecting brand revenue for $NKE. The bill has cleared the House and awaits Senate action. $NKE is a beneficiary but the direct causal chain to Nike's revenue is weaker than the enforcement cost relief for marketplace operators.
Medical Foods and Formulas Access Act of 2025
S.3304 mandates federal health program coverage for medical foods, creating a new guaranteed payment stream for manufacturers. Abbott Laboratories ($ABT), the dominant U.S. player in metabolic formulas through its Nutrition division, is the primary beneficiary. The bill is early-stage (referred to Finance Committee) but has bipartisan sponsorship and an identical House companion, providing moderate legislative momentum.
Employee Profit-Sharing Encouragement Act of 2025
HR6418 is a single-sponsor bill in early legislative stage (referred to Ways and Means). No hearings, no companion bill, no CBO score. The structural link to payroll software providers is indirect and contingent on future legislative action. Market impact is negligible near-term.
No Robot Bosses Act
The No Robot Bosses Act (HR6371) is a procedural early-stage bill with zero near-term market impact. It imposes compliance costs on HR technology vendors but has no funding authorization and has stalled since referral to three committees in December 2025. No actionable trading signal for retail investors at this time.
Schedules That Work Act
HR 6786 (Schedules That Work Act) is stuck in early committee stage with no movement in 132 days. It would raise labor costs for hourly shift workers at retailers, restaurants, and logistics operators, but passage probability is low in this Congress. MCD is already down 5.45% in 30 days on existing margin pressures; this bill adds a legislative tail risk but is not driving current price action.
Other Filings by Rick Larsen
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.